TherapeuticsMD, Inc.TXMDNASDAQ
LOADING
|||
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q3 2025 | -19.42% |
| Q2 2025 | 20.21% |
| Q1 2025 | -173.04% |
| Q4 2024 | 62.86% |
| Q3 2024 | 69.20% |
| Q2 2024 | -144.22% |
| Q1 2024 | 29.11% |
| Q4 2023 | 9.14% |
| Q3 2023 | 28.28% |
| Q2 2023 | 7.31% |
| Q1 2023 | -102.39% |
| Q4 2022 | 637.80% |
| Q3 2022 | -10.12% |
| Q2 2022 | 28.17% |
| Q1 2022 | 25.89% |
| Q4 2021 | 11.34% |
| Q3 2021 | -13.48% |
| Q2 2021 | -20.16% |
| Q1 2021 | 15.40% |
| Q4 2020 | -38.57% |
| Q3 2020 | 44.55% |
| Q2 2020 | 11.55% |
| Q1 2020 | -14.71% |
| Q4 2019 | -63.98% |
| Q3 2019 | 34.98% |
| Q2 2019 | -9.27% |
| Q1 2019 | 0.04% |
| Q4 2018 | -10.94% |
| Q3 2018 | -4.06% |
| Q2 2018 | -33.60% |
| Q1 2018 | -14.00% |
| Q4 2017 | -46.18% |
| Q3 2017 | 25.20% |
| Q2 2017 | 6.84% |
| Q1 2017 | 7.21% |
| Q4 2016 | 8.70% |
| Q3 2016 | -18.47% |
| Q2 2016 | -1.13% |
| Q1 2016 | -19.79% |
| Q4 2015 | 10.22% |